Article Information
History
- August 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Dora Koller, MSc1,
- Susana Almenara, MD1,
- Gina Mejía, MD1,2,
- Miriam Saiz-Rodríguez, PhD1,3,
- Pablo Zubiaur, MPharm1,
- Manuel Román, MLT1,2,
- Dolores Ochoa, MD, PhD1,2,
- Aneta Wojnicz, PhD1,
- Samuel Martín, PhD1,2,
- Daniel Romero-Palacián, MD1,
- Marcos Navares-Gómez, MLT1 and
- Francisco Abad-Santos, MD, PhD1,2,*
- 1Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, School of Medicine, Universidad Autónoma de Madrid, Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain
- 2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain
- 3Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain
- ↵*
Corresponding author
Dr. Francisco Abad-Santos, Clinical Pharmacology Department, Hospital Universitario de La Princesa, Diego de León 62., 28006 Madrid, Spain, Tel: 34 915202425; Fax: 34 915202540, E-mail: francisco.abad{at}salud.madrid.org